DPYSL2 and acute myeloid leukemia: Second, DPYSL2 expressed at higher levels in AML cell lines and patients than in healthy donors, and a high expression level of DPYSL2 was an independent poor prognostic factor for OS, EFS, and RFS in AML patients.